An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer ...

Deep learning model outperformed clinical tools, cutting false positives and enhancing accuracy in CT lung cancer screening ...

bioAffinity Technologies’ noninvasive diagnostic shifted the course of care from watchful waiting for up to 5 years to confirmed malignancy and immediate treatment bioAffinity Technologies, Inc.

CONTEXT: The above video originally aired on September 14th TOPEKA (KSNT) – The University of Kansas Health System St.

An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules achieved high cancer detection rates while significantly reducing false-positive results.

OAK BROOK, Ill. – An artificial intelligence (AI) deep learning tool that estimates the malignancy risk of lung nodules ...

Pulmonologist at Apollo Hospitals Bilaspur, highlights how systemic gaps in diagnosis and access to testing are causing lung cancer to be mislabelled as tuberculosis, delaying life-saving treatment ...

The FANSS shows a 1.3% lung cancer detection rate among 1000 Asian women with no smoking history, which is comparable to ...

Incidental pulmonary nodules are a common finding on chest imaging, but one program is taking an uncommon approach to managing them. Incidental nodules present a growing diagnostic and management ...

Lung cancer screening guidelines do not exist for individuals who never smoked, but data presented at International ...

Detailed price information for Bioaffinity Technologies Inc (BIAF-Q) from The Globe and Mail including charting and trades.